Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium.

Trial Profile

Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2016

At a glance

  • Drugs Vinflunine (Primary) ; Carboplatin; Gemcitabine
  • Indications Urogenital cancer
  • Focus Therapeutic Use
  • Acronyms JASINT1
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 16 Dec 2015 Results published in the Annals of Oncology
    • 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
    • 01 Oct 2013 Preliminary results in the first 43 recruited patients presented at the 2013 European Cancer Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top